Homocysteine level and risk of fracture: A meta-analysis and systematic review

Bone

Volumn 51, Issue 3, 2012, Pages 376-382

  Yang, Jun ^a   Hu, Xinhua ^a   Zhang, Qiang ^a   Cao, Hui ^a   Wang, Junpeng ^a   Liu, Bing ^a  

^a CHINA MEDICAL UNIVERSITY   (China)

Author keywords

Fracture; Homocysteine; Meta analysis

Indexed keywords

CYANOCOBALAMIN; FOLIC ACID; HOMOCYSTEINE; PYRIDOXINE;

ARTICLE; DISEASE ASSOCIATION; EMBASE; FRACTURE; FRACTURE RISK; HOMOCYSTEINE BLOOD LEVEL; HUMAN; HYPERHOMOCYSTEINEMIA; MEDLINE; META ANALYSIS; OBSERVATIONAL STUDY; RANDOMIZED CONTROLLED TRIAL (TOPIC); RISK ASSESSMENT; RISK FACTOR; SYSTEMATIC REVIEW; VITAMIN SUPPLEMENTATION;

CLINICAL TRIALS AS TOPIC; FRACTURES, BONE; HOMOCYSTEINE; HUMANS; PUBLICATION BIAS; QUALITY ASSURANCE, HEALTH CARE; RISK FACTORS;

EID: 84863815467     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.05.024     Document Type: Article

References (38)

1. Christodoulou C., Cooper C. What is osteoporosis?. Postgrad Med J 2003, 79:133-138.
2. Hodsman A.B., Hanley D.A., Josse R. Do bisphosphonates reduce the risk of osteoporotic fractures? An evaluation of the evidence to date. CMAJ 2002, 166:1426-1430.
3. Eastell R., Lambert H. Strategies for skeletal health in the elderly. Proc Nutr Soc 2002, 61:173-180.
4. McLean R.R., Jacques P.F., Selhub J., Tucker K.L., Samelson E.J., Broe K.E., et al. Homocysteine as a predictive factor for hip fracture in older persons. N Engl J Med 2004, 350:2042-2049.
5. van Meurs J.B., Dhonukshe-Rutten R.A., Pluijm S.M., van der Klift M., de Jonge R., Lindemans J., et al. Homocysteine levels and the risk of osteoporotic fracture. N Engl J Med 2004, 350:2033-2041.
6. Villadsen M.M., Bunger M.H., Carstens M., Stenkjaer L., Langdahl B.L. Methylenetetrahydrofolate reductase (MTHFR) C677T polymorphism is associated with osteoporotic vertebral fractures, but is a weak predictor of BMD. Osteoporos Int 2005, 16:411-416.
7. Sato Y., Iwamoto J., Kanoko T., Satoh K. Homocysteine as a predictive factor for hip fracture in elderly women with Parkinson's disease. Am J Med 2005, 118:1250-1255.
8. Sato Y., Honda Y., Iwamoto J., Kanoko T., Satoh K. Homocysteine as a predictive factor for hip fracture in stroke patients. Bone 2005, 36:721-726.
9. Vu T.T., Nguyen T.L., Nguyen C.K., Nguyen T.D., Skeaff C.M., Venn B.J., et al. Folate and vitamin B12 status of women of reproductive age living in Hanoi City and Hai Duong Province of Vietnam. Public Health Nutr 2009, 12:941-946.
10. Cagnacci A., Bagni B., Zini A., Cannoletta M., Generali M., Volpe A. Relation of folates, vitamin B12 and homocysteine to vertebral bone mineral density change in postmenopausal women. A five-year longitudinal evaluation. Bone 2008, 42:314-320.
11. Dose-dependent effects of folic acid on blood concentrations of homocysteine: a meta-analysis of the randomized trials. Am J Clin Nutr 2005, 82:806-812. Homocysteine Lowering Trialists' Collaboration.
12. Clarke R., Lewington S., Sherliker P., Armitage J. Effects of B-vitamins on plasma homocysteine concentrations and on risk of cardiovascular disease and dementia. Curr Opin Clin Nutr Metab Care 2007, 10:32-39.
13. Sato Y., Honda Y., Iwamoto J., Kanoko T., Satoh K. Effect of folate and mecobalamin on hip fractures in patients with stroke: a randomized controlled trial. JAMA 2005, 293:1082-1088.
14. Sawka A.M., Ray J.G., Yi Q., Josse R.G., Lonn E. Randomized clinical trial of homocysteine level lowering therapy and fractures. Arch Intern Med 2007, 167:2136-2139.
15. Gjesdal C.G., Vollset S.E., Ueland P.M., Refsum H., Meyer H.E., Tell G.S. Plasma homocysteine, folate, and vitamin B12 and the risk of hip fracture: the Hordaland homocysteine study. J Bone Miner Res 2007, 22:747-756.
16. Gerdhem P., Ivaska K.K., Isaksson A., Pettersson K., Vaananen H.K., Obrant K.J., et al. Associations between homocysteine, bone turnover, BMD, mortality, and fracture risk in elderly women. J Bone Miner Res 2007, 22:127-134.
17. Perier M.A., Gineyts E., Munoz F., Sornay-Rendu E., Delmas P.D. Homocysteine and fracture risk in postmenopausal women: the OFELY study. Osteoporos Int 2007, 18:1329-1336.
18. Dhonukshe-Rutten R.A., Pluijm S.M., de Groot L.C., Lips P., Smit J.H., van Staveren W.A. Homocysteine and vitamin B12 status relate to bone turnover markers, broadband ultrasound attenuation, and fractures in healthy elderly people. J Bone Miner Res 2005, 20:921-929.
19. Zhu K., Beilby J., Dick I.M., Devine A., Soos M., Prince R.L. The effects of homocysteine and MTHFR genotype on hip bone loss and fracture risk in elderly women. Osteoporos Int 2009, 20:1183-1191.
20. Enneman A.W., van der Velde N., de Jonge R., Heil S.G., Stolk L., Hofman A., et al. The association between plasma homocysteine levels, methylation capacity and incident osteoporotic fractures. Bone 2012, 50:1401-1405.
21. Ravaglia G., Forti P., Maioli F., Servadei L., Martelli M., Brunetti N., et al. Folate, but not homocysteine, predicts the risk of fracture in elderly persons. J Gerontol A Biol Sci Med Sci 2005, 60:1458-1462.
22. Selhub J. The many facets of hyperhomocysteinemia: studies from the Framingham cohorts. J Nutr 2006, 136:1726S-1730S.
23. Stroup D.F., Berlin J.A., Morton S.C., Olkin I., Williamson G.D., Rennie D., et al. Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000, 283:2008-2012.
24. Higgins J.P., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ 2003, 327:557-560.
25. DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trials 1986, 7:177-188.
26. Begg C.B., Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics 1994, 50:1088-1101.
27. Egger M., Davey Smith G., Schneider M., Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997, 315:629-634.
28. McLean R.R., Jacques P.F., Selhub J., Fredman L., Tucker K.L., Samelson E.J., et al. Plasma B vitamins, homocysteine, and their relation with bone loss and hip fracture in elderly men and women. J Clin Endocrinol Metab 2008, 93:2206-2212.
29. van Wijngaarden J.P., Dhonukshe-Rutten R.A., van Schoor N.M., van der Velde N., Swart K.M., Enneman A.W., et al. Rationale and design of the B-PROOF study, a randomized controlled trial on the effect of supplemental intake of vitamin B12 and folic acid on fracture incidence. BMC Geriatr 2011, 11:80.
30. Hodgson S.F., Watts N.B., Bilezikian J.P., Clarke B.L., Gray T.K., Harris D., et al. American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003. Endocr Pract 2003, 9:544-564.
31. Hosking D.J., Geusens P., Rizzoli R. Osteoporosis therapy: an example of putting evidence-based medicine into clinical practice. QJM 2005, 98:403-413.
32. Yazdanpanah N., Zillikens M.C., Rivadeneira F., de Jong R., Lindemans J., Uitterlinden A.G., et al. Effect of dietary B vitamins on BMD and risk of fracture in elderly men and women: the Rotterdam study. Bone 2007, 41:987-994.
33. Leboff M.S., Narweker R., LaCroix A., Wu L., Jackson R., Lee J., et al. Homocysteine levels and risk of hip fracture in postmenopausal women. J Clin Endocrinol Metab 2009, 94:1207-1213.
34. Kuo H.K., Liao K.C., Leveille S.G., Bean J.F., Yen C.J., Chen J.H., et al. Relationship of homocysteine levels to quadriceps strength, gait speed, and late-life disability in older adults. J Gerontol A Biol Sci Med Sci 2007, 62:434-439.
35. Saito M., Fujii K., Marumo K. Degree of mineralization-related collagen crosslinking in the femoral neck cancellous bone in cases of hip fracture and controls. Calcif Tissue Int 2006, 79:160-168.
36. Krumdieck C.L., Prince C.W. Mechanisms of homocysteine toxicity on connective tissues: implications for the morbidity of aging. J Nutr 2000, 130:365S-368S.
37. den Heijer M., Graafsma S., Lee S.Y., van Landeghem B., Kluijtmans L., Verhoef P., et al. Homocysteine levels-before and after methionine loading-in 51 Dutch families. Eur J Hum Genet 2005, 13:753-762.
38. Jee S.H., Song K.S., Shim W.H., Kim H.K., Suh I., Park J.Y., et al. Major gene evidence after MTHFR-segregation analysis of serum homocysteine in families of patients undergoing coronary arteriography. Hum Genet 2002, 111:128-135.